版本:
中国

BRIEF-Veracyte releases statement on CMS's final 2017 gapfill rate for afirma gene expression classifier

Sept 30 Veracyte Inc :

* Veracyte releases statement on cms's final 2017 gapfill rate for afirma gene expression classifier

* Believe this new rate is still based on a flawed application of cms gapfill criteria. Plan to file reconsideration request with CMS

Source text for Eikon:

Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐